# Safety and Survival of Genetically Modified White Blood Cells in HIV-infected Twins The Gemini Study

> **NCT04799483** · — · ACTIVE_NOT_RECRUITING · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 32 (estimated)

## Conditions studied

- HIV

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04799483
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2001-01-05
- **Primary completion:** 2030-01-01
- **Final completion:** 2030-01-30
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2024-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04799483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04799483, "Safety and Survival of Genetically Modified White Blood Cells in HIV-infected Twins The Gemini Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04799483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*